# Pineapple Financial Inc.: financial statements, quarterly

PAPL · NYSE · CIK 1938109 · [Financials](/sectors/financials.md)

Pages: [Overview](/companies/papl.md) · [Financials](/companies/papl/financials.md) · [Filings](/companies/papl/filings.md) · [Insiders](/companies/papl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/papl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.6 d](/filings/0001493152-24-051101.md) | [0.6](/filings/0001493152-25-002938.md) | [0.8](/filings/0001641172-25-004579.md) | [0.7](/filings/0001641172-25-019521.md) | [0.7 d](/filings/0001493152-25-025962.md) | [0.8](/filings/0001493152-26-002942.md) | [0.7](/filings/0001493152-26-016374.md) | [0.7](/filings/0001493152-26-033926.md) | [0.7 d](/filings/0001493152-25-025962.md) | [0.7](/filings/0001493152-26-002942.md) | [0.7](/filings/0001493152-26-016374.md) | [0.6](/filings/0001493152-26-033926.md) |
| Cost of revenue | $m | [0.3 d](/filings/0001493152-24-051101.md) | [0.3](/filings/0001493152-25-002938.md) | [0.3](/filings/0001641172-25-004579.md) | [0.4](/filings/0001641172-25-019521.md) | [0.4 d](/filings/0001493152-25-025962.md) | [0.4](/filings/0001493152-26-002942.md) | [0.4](/filings/0001493152-26-016374.md) | [0.2](/filings/0001493152-26-033926.md) | [0.5 d](/filings/0001493152-25-025962.md) | [0.4](/filings/0001493152-26-002942.md) | [0.4](/filings/0001493152-26-016374.md) | [0.3](/filings/0001493152-26-033926.md) |
| Selling, general and administrative | $m | [0.6 d](/filings/0001493152-24-051101.md) | [0.6](/filings/0001493152-25-002938.md) | [0.6](/filings/0001641172-25-004579.md) | [0.5](/filings/0001641172-25-019521.md) | [0.8 d](/filings/0001493152-25-025962.md) | [0.4](/filings/0001493152-26-002942.md) | [0.6](/filings/0001493152-26-016374.md) | [0.5](/filings/0001493152-26-033926.md) | [0.7 d](/filings/0001493152-25-025962.md) | [0.4](/filings/0001493152-26-002942.md) | [0.7](/filings/0001493152-26-016374.md) | [0.6](/filings/0001493152-26-033926.md) |
| Operating income | $m | [(0.6) d](/filings/0001493152-24-051101.md) | [(0.9)](/filings/0001493152-25-002938.md) | [(0.7)](/filings/0001641172-25-004579.md) | [(0.9)](/filings/0001641172-25-019521.md) | [(1.4) d](/filings/0001493152-25-025962.md) | [(0.7)](/filings/0001493152-26-002942.md) | [(0.6)](/filings/0001493152-26-016374.md) | [(0.7)](/filings/0001493152-26-033926.md) | [(1.0) d](/filings/0001493152-25-025962.md) | [(6.6)](/filings/0001493152-26-002942.md) | [(17.8)](/filings/0001493152-26-016374.md) | [24.9](/filings/0001493152-26-033926.md) |
| Interest expense | $m | not reported | [0.0](/filings/0001493152-24-002452.md) | [0.0](/filings/0001493152-24-014615.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(0.6) d](/filings/0001493152-24-051101.md) | [(0.9)](/filings/0001493152-25-002938.md) | [(0.7)](/filings/0001641172-25-004579.md) | [(0.8)](/filings/0001641172-25-019521.md) | [(1.7)](/filings/0001641172-25-019521.md) | [(0.7)](/filings/0001493152-26-002942.md) | [(0.6)](/filings/0001493152-26-016374.md) | [(0.6)](/filings/0001493152-26-033926.md) | [(1.8) d](/filings/0001493152-25-025962.md) | [(6.4)](/filings/0001493152-26-002942.md) | [(19.5)](/filings/0001493152-26-016374.md) | [25.3](/filings/0001493152-26-033926.md) |
| Diluted EPS | $ per share | not reported | [(0.14)](/filings/0001493152-25-002938.md) | [(0.10)](/filings/0001641172-25-004579.md) | [(0.12)](/filings/0001641172-25-019521.md) | not reported | [(2.60)](/filings/0001493152-26-002942.md) | [(1.73)](/filings/0001493152-26-016374.md) | [(0.93)](/filings/0001493152-26-033926.md) | not reported | [(4.79)](/filings/0001493152-26-002942.md) | [(1.21)](/filings/0001493152-26-016374.md) | [0.99](/filings/0001493152-26-033926.md) |
| Basic EPS | $ per share | not reported | [(0.14)](/filings/0001493152-25-002938.md) | [(0.10)](/filings/0001641172-25-004579.md) | [(0.12)](/filings/0001641172-25-019521.md) | not reported | [(2.60)](/filings/0001493152-26-002942.md) | [(1.73)](/filings/0001493152-26-016374.md) | [(0.93)](/filings/0001493152-26-033926.md) | not reported | [(4.79)](/filings/0001493152-26-002942.md) | [(1.21)](/filings/0001493152-26-016374.md) | [0.99](/filings/0001493152-26-033926.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | FY2024 (2024-08-31) | period not labelled (2024-10-22) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.3](/filings/0001493152-24-002452.md) | [1.3](/filings/0001493152-24-014615.md) | [0.7](/filings/0001493152-24-027861.md) | [0.6](/filings/0001493152-25-025962.md) | not reported | [0.6](/filings/0001493152-25-002938.md) | [0.5](/filings/0001641172-25-004579.md) | [1.1](/filings/0001641172-25-019521.md) | [2.1](/filings/0001493152-26-033926.md) | [1.5](/filings/0001493152-26-002942.md) | [17.7](/filings/0001493152-26-016374.md) | [5.1](/filings/0001493152-26-033926.md) |
| Current assets | $m | [3.4](/filings/0001493152-24-002452.md) | [2.4](/filings/0001493152-24-014615.md) | [1.1](/filings/0001493152-24-027861.md) | [0.9](/filings/0001493152-25-025962.md) | not reported | [1.0](/filings/0001493152-25-002938.md) | [0.9](/filings/0001641172-25-004579.md) | [1.4](/filings/0001641172-25-019521.md) | [2.3](/filings/0001493152-26-033926.md) | [1.8](/filings/0001493152-26-002942.md) | [23.4](/filings/0001493152-26-016374.md) | [23.5](/filings/0001493152-26-033926.md) |
| Total assets | $m | [6.4](/filings/0001493152-24-002452.md) | [5.6](/filings/0001493152-24-014615.md) | [4.3](/filings/0001493152-24-027861.md) | [4.1](/filings/0001493152-25-025962.md) | not reported | [4.1](/filings/0001493152-25-002938.md) | [4.0](/filings/0001641172-25-004579.md) | [4.7](/filings/0001641172-25-019521.md) | [5.4](/filings/0001493152-26-033926.md) | [10.6](/filings/0001493152-26-002942.md) | [48.9](/filings/0001493152-26-016374.md) | [75.9](/filings/0001493152-26-033926.md) |
| Current liabilities | $m | [1.1](/filings/0001493152-24-002452.md) | [1.2](/filings/0001493152-24-014615.md) | [0.7](/filings/0001493152-24-027861.md) | [1.4](/filings/0001493152-25-025962.md) | not reported | [1.8](/filings/0001493152-25-002938.md) | [2.1](/filings/0001641172-25-004579.md) | [2.4](/filings/0001641172-25-019521.md) | [3.6](/filings/0001493152-26-033926.md) | [14.8](/filings/0001493152-26-002942.md) | [20.3](/filings/0001493152-26-016374.md) | [23.5](/filings/0001493152-26-033926.md) |
| Total liabilities | $m | [2.8](/filings/0001493152-24-002452.md) | [2.6](/filings/0001493152-24-014615.md) | [2.3](/filings/0001493152-24-027861.md) | [2.7](/filings/0001493152-25-025962.md) | not reported | [3.0](/filings/0001493152-25-002938.md) | [3.2](/filings/0001641172-25-004579.md) | [3.9](/filings/0001641172-25-019521.md) | [4.5](/filings/0001493152-26-033926.md) | [16.1](/filings/0001493152-26-002942.md) | [21.8](/filings/0001493152-26-016374.md) | [24.2](/filings/0001493152-26-033926.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | [0.5](/filings/0001641172-25-004579.md) | not reported | not reported | [0.6](/filings/0001641172-25-019521.md) | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [3.6](/filings/0001493152-25-002938.md) | [2.9](/filings/0001641172-25-004579.md) | [2.0](/filings/0001641172-25-019521.md) | [1.3](/filings/0001493152-26-033926.md) | not reported | [1.3](/filings/0001493152-26-002942.md) | [0.7](/filings/0001493152-26-016374.md) | [0.8](/filings/0001493152-26-033926.md) | [0.9](/filings/0001493152-26-033926.md) | [(5.5)](/filings/0001493152-26-002942.md) | [27.1](/filings/0001493152-26-016374.md) | [51.6](/filings/0001493152-26-033926.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(173) d](/filings/0001493152-24-051101.md) | [(1,023)](/filings/0001493152-25-002938.md) | [(544) d](/filings/0001641172-25-004579.md) | [123 d](/filings/0001641172-25-019521.md) | [(265) d](/filings/0001493152-25-025962.md) | [(664)](/filings/0001493152-26-002942.md) | [(173) d](/filings/0001493152-26-016374.md) | [397 d](/filings/0001493152-26-033926.md) | [(508) d](/filings/0001493152-25-025962.md) | [(490)](/filings/0001493152-26-002942.md) | [(3,273) d](/filings/0001493152-26-016374.md) | [(859) d](/filings/0001493152-26-033926.md) |
| Capital expenditure | $k | [10.9 d](/filings/0001493152-24-051101.md) | [2.0](/filings/0001493152-25-002938.md) | [2.6 d](/filings/0001641172-25-004579.md) | [0.3 d](/filings/0001641172-25-019521.md) | [0.0 d](/filings/0001493152-25-025962.md) | not reported | not reported | not reported | not reported | [1.9](/filings/0001493152-26-002942.md) | [0.0 d](/filings/0001493152-26-016374.md) | [0.0 d](/filings/0001493152-26-033926.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2022-11-30) | period not labelled (2023-02-28) | period not labelled (2023-05-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.3](/filings/0001493152-24-002452.md) | [6.3](/filings/0001493152-24-014615.md) | [6.3](/filings/0001493152-24-027861.md) | [6.6](/filings/0001493152-25-002938.md) | [6.5](/filings/0001641172-25-004579.md) | [7.2](/filings/0001641172-25-019521.md) | [0.4](/filings/0001493152-26-002942.md) | [0.5](/filings/0001493152-26-016374.md) | [0.6](/filings/0001493152-26-033926.md) | [1.3](/filings/0001493152-26-002942.md) | [16.2](/filings/0001493152-26-016374.md) | [25.6](/filings/0001493152-26-033926.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 25,271,197 at 2026-07-20, from the cover of the [10-Q filed 2026-07-20](/filings/0001493152-26-033926.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.